Clearside Biomedical Inc
NASDAQ:CLSD

Watchlist Manager
Clearside Biomedical Inc Logo
Clearside Biomedical Inc
NASDAQ:CLSD
Watchlist
Price: 0.8797 USD 0.85% Market Closed
Market Cap: 66.7m USD
Have any thoughts about
Clearside Biomedical Inc?
Write Note

Wall Street
Price Targets

CLSD Price Targets Summary
Clearside Biomedical Inc

Wall Street analysts forecast CLSD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CLSD is 6.12 USD with a low forecast of 5.05 USD and a high forecast of 8.4 USD.

Lowest
Price Target
5.05 USD
474% Upside
Average
Price Target
6.12 USD
596% Upside
Highest
Price Target
8.4 USD
855% Upside
Clearside Biomedical Inc Competitors:
Price Targets
OFSA3
Ouro Fino Saude Animal Participacoes SA
10% Upside
ZYDUSLIFE
Zydus Lifesciences Ltd
14% Upside
AGY
Allergy Therapeutics PLC
110% Upside
600566
Hubei Jumpcan Pharmaceutical Co Ltd
81% Upside
CRON
Cronos Group Inc
27% Upside
AXSM
Axsome Therapeutics Inc
54% Upside
CTLT
Catalent Inc
2% Upside
GUD
Knight Therapeutics Inc
38% Upside

Revenue
Forecast

Revenue Estimate
Clearside Biomedical Inc

The compound annual growth rate of Clearside Biomedical Inc's revenue for the next 4 years is 30%.

N/A
Past Growth
30%
Estimated Growth
Estimates Accuracy
17%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Clearside Biomedical Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Clearside Biomedical Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-52%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CLSD's stock price target?
Price Target
6.12 USD

According to Wall Street analysts, the average 1-year price target for CLSD is 6.12 USD with a low forecast of 5.05 USD and a high forecast of 8.4 USD.

What is Clearside Biomedical Inc's Revenue forecast?
Projected CAGR
30%

The compound annual growth rate of Clearside Biomedical Inc's revenue for the next 4 years is 30%.

Back to Top